Development of Gene Therapies: Strategic, Scientific, Regulatory, and Access Considerations (Chapman & Hall/CRC Biostatistics Series) - Image 1

£165.91

Chapman and Hall/CRC Development of Gene Therapies: Strategic, Scientific, Regulatory, and Access Considerations (Chapman & Hall/CRC Biostatistics Series)

Name: Development of Gene Therapies: Strategic, Scientific, Regulatory, and Access Considerations (Chapman & Hall/CRC Biostatistics Series)
Brand: Chapman and Hall/CRC
Price: 165.91 GBP
Availability: InStock

Economics

This is the usual price. Wait for it to drop, or tell us your number.

£166 today · usual range £155–£166 · best ever £155

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 76 days · 76 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 76 days • 3 price levels

Days at Price

Current Price

Price Analysis

Most common price: £166 (37 days, 48.7%)

Price range: £155 - £166

Price levels: 3 different prices over 76 days

Description

One of the recent advances in 21st century medicine is the emergence of gene therapies, drugs that affect the basic biology of genetic disease. The field has seen some notable setbacks in the past, but in recent years has exploded as decades of basic science have been successfully translated into the most complex biologics ever constructed, leading to regulatory approval of several gene therapy products in oncology, hematology, neurology, and ophthalmology indications. These drugs are at the apex of biological manufacturing complexity, and have the potential to be disease modifying or even curative. Evidence-based and innovative quantitative clinical development and lifecycle management strategies will be required as fixtures in the development for these unique drugs in order to reach patients in need. Development of Gene Therapies: Strategic, Scientific, and Regulatory Considerations is an unparalleled summary of the current scientific, statistical, developmental, and regulatory aspects of gene therapies, which is fast becoming a core area of the biopharmaceutical industry. This edited volume provides a systematic description of core development topics in gene therapies through 19 peer-reviewed chapters written by subject matter experts in the field. This edited volume is an invaluable resource for business leaders and investors hoping to understand the scientific principles and strategy of a company they may potentially invest in; the family members of someone affected by a genetic disease who wish to understand better how these therapies work and what they might expect as a treatment for a loved one; academic professionals, who want to learn and teach incoming medical, public health, or business students; and seasoned drug developers, who wish to learn more about the about the cutting edge of biopharmaceutical drug development. Key Features: Provides a thorough background on the scientific, manufacturing, and translational concepts and competencies for gene therapies. Covers important strategic aspects of the gene therapy industry, thereby helping investors, drug developers, and regulators gain a better appreciation of the potential value of gene therapies. Expounds on many existing and emerging state-of-the art scientific and technological advances, as well as ethical, pharmacovigilance, and regulatory considerations for gene therapy product development. Presents several case studies of successful development of gene therapies, including two of the most remarkable FDA-approved gene therapy products: Zolgensma and Luxturna. Provides perspectives and forward-looking statements on the future of gene therapies in neurological, in utero, and ultra-rare indications.

Product Specifications

Brand: Chapman and Hall/CRC
Format: hardcover
ASIN: 1032136553
Category: Books > Subjects > Business, Finance & Law > Economics
Domain: Amazon UK
Release Date: 23 May 2024
Listed Since: 13 September 2023

Barcode

No barcode data available

Chapman and Hall/CRC Development of Gene Therapies: Strategic, Scientific, Regulatory, and Access Considerations (Chapman & Hall/CRC Biostatistics Series)

This is the usual price. Wait for it to drop, or tell us your number.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

The Development of Human Gene Therapy (Monograph): v. 36

Gene Therapy: Principles and Challenges

Gene Therapy of Cancer: Methods and Protocols: 2521 (Methods in Molecular Biology, 2521)

Gene Therapy Applications

Targets in Gene Therapy

Gene Transfer, Genome Editing And Gene Therapy: Principles And Strategies

Gene Therapy: Biological Aspects and Applications

Integration of Biomaterials for Gene Therapy

Textbook of Gene Therapy: Principles and Applications

Regulatory Aspects of Gene Therapy and Cell Therapy Products: A Global Perspective: 1430 (Advances in Experimental Medicine and Biology, 1430)

Regulatory Aspects of Gene Therapy and Cell Therapy Products: A Global Perspective: 871 (Advances in Experimental Medicine and Biology)

Current Approaches in Gene Therapy

Simultaneous Global New Drug Development: Multi-Regional Clinical Trials after ICH E17 (Chapman & Hall/CRC Biostatistics Series)

Quantitative Methods for Precision Medicine: Pharmacogenomics in Action (Chapman & Hall/CRC Biostatistics Series)

Genetic Disease Discovery and Therapeutics (Advanced Topics in Biomaterials)

Biological Processes and Genetic Engineering

Gene Expression and Control

Prodrug Gene Therapy Vectors in Combination Therapies: An update

La thérapie génique et ses applications dans le traitement des maladies

Gene Therapy in Reconstructive and Regenerative Surgery

Gemini Surfactant-Based Gene Therapy: Non-invasive gene delivery

Recent Trends in Gene Expression (Genetics - Research and Issues)

Royal Society of Chemistry - Biomaterial Control of Stem Cells

Diagnostics and Gene Therapy for Human Genetic Disorders